(Q68873323)
Statements
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma (English)
Gadducci A
Ferdeghini M
Ceccarini T
Prontera C
Facchini V
Bianchi R
1 January 1990